ATE551353T1 - Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten - Google Patents

Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten

Info

Publication number
ATE551353T1
ATE551353T1 AT04725350T AT04725350T ATE551353T1 AT E551353 T1 ATE551353 T1 AT E551353T1 AT 04725350 T AT04725350 T AT 04725350T AT 04725350 T AT04725350 T AT 04725350T AT E551353 T1 ATE551353 T1 AT E551353T1
Authority
AT
Austria
Prior art keywords
protein
syncitin
fusogenic
activity similar
sequence
Prior art date
Application number
AT04725350T
Other languages
English (en)
Inventor
Thierry Heidmann
Marie Dewannieux
Sandra Blaise
Laurence Benit
Parseval Nathalie De
Vladimir Lazar
Marianne Mangeney
Original Assignee
Centre Nat Rech Scient
I N S E R M Inst Nat De La Sante Et De La Rech Medicale
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, I N S E R M Inst Nat De La Sante Et De La Rech Medicale, Roussy Inst Gustave filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE551353T1 publication Critical patent/ATE551353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AT04725350T 2003-04-04 2004-04-02 Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten ATE551353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45997403P 2003-04-04 2003-04-04
PCT/EP2004/003552 WO2004087748A1 (en) 2003-04-04 2004-04-02 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same

Publications (1)

Publication Number Publication Date
ATE551353T1 true ATE551353T1 (de) 2012-04-15

Family

ID=33131908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04725350T ATE551353T1 (de) 2003-04-04 2004-04-02 Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten

Country Status (3)

Country Link
EP (1) EP1651667B1 (de)
AT (1) ATE551353T1 (de)
WO (1) WO2004087748A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103562A2 (en) 2005-03-30 2006-10-05 Centre National De La Recherche Scientifique (Cnrs) Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment
JP7037486B2 (ja) * 2015-10-01 2022-03-16 エイムヴィオン・アクティエセルスカブ 医薬としてのヒト由来免疫抑制タンパク質およびペプチドの使用
EP3235828A1 (de) * 2016-04-21 2017-10-25 Genethon Stabile pseudotypisierte lentivirale teilchen und verwendungen davon
EP3504224A1 (de) 2016-08-23 2019-07-03 Aimvion A/S Neuartige immunstimulierende peptide
AU2018266111A1 (en) 2017-05-08 2019-11-21 Flagship Pioneering Innovations V, Inc. Compositions for facilitating membrane fusion and uses thereof
CN111225682A (zh) * 2017-10-20 2020-06-02 吉尼松公司 合胞素用于将药物和基因靶向递送至肺组织的用途
CN111246874A (zh) * 2017-10-20 2020-06-05 吉尼松公司 合胞素用于将药物和基因靶向递送至再生肌肉组织的用途
WO2020061229A2 (en) 2018-09-18 2020-03-26 Vnv Newco Inc. Arc-based capsids and uses thereof
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides
WO2023166347A1 (en) * 2022-03-04 2023-09-07 Institut Pasteur Uptake mechanism of essential lysophospholipids into the brain and inhibition by endogenous-retroviral envelope protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797889A1 (fr) 1999-09-01 2001-03-02 Bio Merieux Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides

Also Published As

Publication number Publication date
WO2004087748A1 (en) 2004-10-14
EP1651667B1 (de) 2012-03-28
EP1651667A1 (de) 2006-05-03

Similar Documents

Publication Publication Date Title
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
AR047347A1 (es) Miembros de la familia cry9 de bacillus
EP2476699A3 (de) Peptidvakzinen für MPHOSPH1- oder DEPDC1-Polypeptide exprimierenden Krebs
NZ602351A (en) Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
MX2008009493A (es) Peptido novedoso y uso del mismo.
MX2010002001A (es) Peptido cdca1 y agente farmaceutico que comprende elmismo.
MX2010002018A (es) Peptido de cdh3 y agente medicinal que comprende al mismo.
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
AU4653301A (en) Anti-freeze proteins, their production and use
BR112022012057A2 (pt) Novos métodos de entrega celular
EP1796707A4 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
HK1147210A1 (en) Anti-hypertensive agent
WO2022133333A3 (en) Compositions and method of use for hair straightening and shaping
WO2018200814A3 (en) Modified cyclic peptides and therapeutic use thereof
MY182816A (en) Cancer antigen peptide
GB2441941A (en) An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide
ATE286535T1 (de) Regulatorisches protein pke 83 aus humanen keratinozyten